Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha

Angelamellisy Revelian Ndibalema,1,2 Deo Kabuye,3,4 Si Wen,1 Lulu Li,1 Xin Li,1 Qiuling Fan1 1Department of Nephrology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China; 2Kairuki Hospital, Dar es Salaam, Tanzania; 3Department of Laboratory Medicin...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ndibalema AR, Kabuye D, Wen S, Li L, Li X, Fan Q
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	humans animals transforming growth factor beta1 empagliflozin diabetic nephropathies glucose. Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/a643b230f7d6409eb67c42e9d3aa3e48
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a643b230f7d6409eb67c42e9d3aa3e48
record_format	dspace
spelling	oai:doaj.org-article:a643b230f7d6409eb67c42e9d3aa3e482021-12-02T10:23:03ZEmpagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha1178-7007https://doaj.org/article/a643b230f7d6409eb67c42e9d3aa3e482020-06-01T00:00:00Zhttps://www.dovepress.com/empagliflozin-protects-against-proximal-renal-tubular-cell-injury-indu-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Angelamellisy Revelian Ndibalema,1,2 Deo Kabuye,3,4 Si Wen,1 Lulu Li,1 Xin Li,1 Qiuling Fan1 1Department of Nephrology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China; 2Kairuki Hospital, Dar es Salaam, Tanzania; 3Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, 110001, People’s Republic of China; 4Kalisizo Hospital Uganda, Kalisizo, UgandaCorrespondence: Qiuling Fan Tel +86 13904012680Email cmufql@163.comBackground: Evidence from both animal and human studies clearly supports the renal beneficial effects of empagliflozin (emp), a sodium glucose co-transporter 2 (SGLT2) inhibitor, but the mechanism in which it exerts its effect is not well understood. In this study, we investigated the capability of emp on reducing hyperglycemia-induced renal proximal tubular epithelial cells injury and we evaluated if the renoprotective effect of emp associates with hypoxia-inducible factor-1α (HIF-1α).Materials and Methods: Human kidney cell lines (HK-2 cells) were incubated in normoxia, high glucose with or without emp treatment for 72 hours to evaluate the induction of HIF-1α, glucose transporter-1, SGLT2, the fibrosis signal pathway and epithelial–mesenchymal transition (EMT) markers.Results: High glucose (HG) increased expression of Collagen IV, Fibronectin, transforming growth factor-beta1 (TGF-β 1). However, emp treatment remarkably decreased expression of TGF-β 1, accumulation of extracellular matrix proteins (Fibronectin, Collagen IV), as well as (phosphorylated-smad3) P-smad3. HG increased SGLT2 protein expression compared to normal glucose (NG) while emp significantly decreased SGLT2 expression. Furthermore, emp decreased high glucose-induced alpha-smooth muscle actin (α-SMA) expression and reversed epithelial marker (E-catherin) suppression induced by high glucose. In addition, emp treatment for 72 h increased expression of HIF-1α protein (95% CI: -0.5918 to – 0.002338, at 100nM, P < 0.05, 95% CI – 0.6631 to – 0.07367 at 500nM, P < 0.05) in hyperglycemic normoxic HK-2 cells. Furthermore, we observed increased expression of GLUT-1 protein after emp treatment and remarkably decreased cell proliferation.Conclusion: Emp treatment protected proximal renal tubular cells injury induced by high glucose. Induction of HIF-1α expression by emp may play an essential role in the protection of high glucose-induced proximal renal tubular epithelial cells injury.Keywords: humans, animals, transforming growth factor-beta1, empagliflozin, diabetic nephropathies, glucoseNdibalema ARKabuye DWen SLi LLi XFan QDove Medical Pressarticlehumansanimalstransforming growth factor beta1empagliflozindiabetic nephropathiesglucose.Specialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 13, Pp 1953-1967 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	humans animals transforming growth factor beta1 empagliflozin diabetic nephropathies glucose. Specialties of internal medicine RC581-951
spellingShingle	humans animals transforming growth factor beta1 empagliflozin diabetic nephropathies glucose. Specialties of internal medicine RC581-951 Ndibalema AR Kabuye D Wen S Li L Li X Fan Q Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha
description	Angelamellisy Revelian Ndibalema,1,2 Deo Kabuye,3,4 Si Wen,1 Lulu Li,1 Xin Li,1 Qiuling Fan1 1Department of Nephrology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China; 2Kairuki Hospital, Dar es Salaam, Tanzania; 3Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, 110001, People’s Republic of China; 4Kalisizo Hospital Uganda, Kalisizo, UgandaCorrespondence: Qiuling Fan Tel +86 13904012680Email cmufql@163.comBackground: Evidence from both animal and human studies clearly supports the renal beneficial effects of empagliflozin (emp), a sodium glucose co-transporter 2 (SGLT2) inhibitor, but the mechanism in which it exerts its effect is not well understood. In this study, we investigated the capability of emp on reducing hyperglycemia-induced renal proximal tubular epithelial cells injury and we evaluated if the renoprotective effect of emp associates with hypoxia-inducible factor-1α (HIF-1α).Materials and Methods: Human kidney cell lines (HK-2 cells) were incubated in normoxia, high glucose with or without emp treatment for 72 hours to evaluate the induction of HIF-1α, glucose transporter-1, SGLT2, the fibrosis signal pathway and epithelial–mesenchymal transition (EMT) markers.Results: High glucose (HG) increased expression of Collagen IV, Fibronectin, transforming growth factor-beta1 (TGF-β 1). However, emp treatment remarkably decreased expression of TGF-β 1, accumulation of extracellular matrix proteins (Fibronectin, Collagen IV), as well as (phosphorylated-smad3) P-smad3. HG increased SGLT2 protein expression compared to normal glucose (NG) while emp significantly decreased SGLT2 expression. Furthermore, emp decreased high glucose-induced alpha-smooth muscle actin (α-SMA) expression and reversed epithelial marker (E-catherin) suppression induced by high glucose. In addition, emp treatment for 72 h increased expression of HIF-1α protein (95% CI: -0.5918 to – 0.002338, at 100nM, P < 0.05, 95% CI – 0.6631 to – 0.07367 at 500nM, P < 0.05) in hyperglycemic normoxic HK-2 cells. Furthermore, we observed increased expression of GLUT-1 protein after emp treatment and remarkably decreased cell proliferation.Conclusion: Emp treatment protected proximal renal tubular cells injury induced by high glucose. Induction of HIF-1α expression by emp may play an essential role in the protection of high glucose-induced proximal renal tubular epithelial cells injury.Keywords: humans, animals, transforming growth factor-beta1, empagliflozin, diabetic nephropathies, glucose
format	article
author	Ndibalema AR Kabuye D Wen S Li L Li X Fan Q
author_facet	Ndibalema AR Kabuye D Wen S Li L Li X Fan Q
author_sort	Ndibalema AR
title	Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha
title_short	Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha
title_full	Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha
title_fullStr	Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha
title_full_unstemmed	Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha
title_sort	empagliflozin protects against proximal renal tubular cell injury induced by high glucose via regulation of hypoxia-inducible factor 1-alpha
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/a643b230f7d6409eb67c42e9d3aa3e48
work_keys_str_mv	AT ndibalemaar empagliflozinprotectsagainstproximalrenaltubularcellinjuryinducedbyhighglucoseviaregulationofhypoxiainduciblefactor1alpha AT kabuyed empagliflozinprotectsagainstproximalrenaltubularcellinjuryinducedbyhighglucoseviaregulationofhypoxiainduciblefactor1alpha AT wens empagliflozinprotectsagainstproximalrenaltubularcellinjuryinducedbyhighglucoseviaregulationofhypoxiainduciblefactor1alpha AT lil empagliflozinprotectsagainstproximalrenaltubularcellinjuryinducedbyhighglucoseviaregulationofhypoxiainduciblefactor1alpha AT lix empagliflozinprotectsagainstproximalrenaltubularcellinjuryinducedbyhighglucoseviaregulationofhypoxiainduciblefactor1alpha AT fanq empagliflozinprotectsagainstproximalrenaltubularcellinjuryinducedbyhighglucoseviaregulationofhypoxiainduciblefactor1alpha
_version_	1718397364152041472

Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha

Ejemplares similares